Experienced in Sinusitis

Chuanjian F. Lu

No. 87, Xiangya Road, 
Changsha, CN 
Experienced in Sinusitis
No. 87, Xiangya Road, 
Changsha, CN 
OverviewLocationsClinical Research

Overview

Chuanjian Lu practices in Changsha, China. Lu is rated as an Experienced expert by MediFind in the treatment of Sinusitis. Their top areas of expertise are Psoriasis, Necrosis, Hives, Sinusitis, and Splenectomy.

Their clinical research consists of co-authoring 181 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Sinusitis.

Locations

No. 87, Xiangya Road, Changsha, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Safety and Efficacy of Expanded Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Moderate to Severe Psoriasis
Safety and Efficacy of Expanded Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Moderate to Severe Psoriasis
Enrollment Status: Completed
Publish Date: August 25, 2023
Intervention Type: Biological
Study Drug: Adipose-Derived Multipotent Mesenchymal Stem Cells
Study Phase: Phase 1/Phase 2
Efficacy and Safety of Expanded Allogeneic Adipose-derived Mesenchymal Stem Cells Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis
Efficacy and Safety of Expanded Allogeneic Adipose-derived Mesenchymal Stem Cells Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis
Enrollment Status: Completed
Publish Date: August 24, 2023
Intervention Type: Drug, Biological
Study Drugs: Calcipotriol Ointment, Adipose-Derived Multipotent Mesenchymal Stem Cells
Study Phase: Phase 1/Phase 2
Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Patients With Moderate to Severe Psoriasis
Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Patients With Moderate to Severe Psoriasis
Enrollment Status: Completed
Publish Date: August 24, 2023
Intervention Type: Drug, Biological
Study Drugs: Calcipotriol ointment, PSORI-CM01 Granule, Adipose-derived multipotent mesenchymal stem cells
Study Phase: Not Applicable
View 2 Less Clinical Trials

181 Total Publications

A Multicenter Validation of a Fully Automated Chemiluminescence Immunoassay for Plasma Elafin in Psoriasis Diagnosis and Severity Assessment.
A Multicenter Validation of a Fully Automated Chemiluminescence Immunoassay for Plasma Elafin in Psoriasis Diagnosis and Severity Assessment.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 23, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Lu's expertise for a condition
ConditionClose
      View All 20 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile